DOSEF
Price
$0.54
Change
+$0.19 (+54.29%)
Updated
Jun 23 closing price
Capitalization
2.88M
MNPR
Price
$34.00
Change
-$1.01 (-2.88%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
214.09M
Interact to see
Advertisement

DOSEF vs MNPR

Header iconDOSEF vs MNPR Comparison
Open Charts DOSEF vs MNPRBanner chart's image
Doseology Sciences
Price$0.54
Change+$0.19 (+54.29%)
Volume$550
Capitalization2.88M
Monopar Therapeutics
Price$34.00
Change-$1.01 (-2.88%)
Volume$1.26K
Capitalization214.09M
DOSEF vs MNPR Comparison Chart in %
Loading...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DOSEF vs. MNPR commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOSEF is a Hold and MNPR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (DOSEF: $0.54 vs. MNPR: $35.01)
Brand notoriety: DOSEF and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOSEF: 12% vs. MNPR: 113%
Market capitalization -- DOSEF: $2.88M vs. MNPR: $214.09M
DOSEF [@Biotechnology] is valued at $2.88M. MNPR’s [@Biotechnology] market capitalization is $214.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOSEF’s FA Score shows that 0 FA rating(s) are green whileMNPR’s FA Score has 0 green FA rating(s).

  • DOSEF’s FA Score: 0 green, 5 red.
  • MNPR’s FA Score: 0 green, 5 red.
According to our system of comparison, MNPR is a better buy in the long-term than DOSEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNPR’s TA Score shows that 5 TA indicator(s) are bullish.

  • MNPR’s TA Score: 5 bullish, 4 bearish.

Price Growth

DOSEF (@Biotechnology) experienced а +54.06% price change this week, while MNPR (@Biotechnology) price change was +6.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

MNPR is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNPR($214M) has a higher market cap than DOSEF($2.89M). DOSEF YTD gains are higher at: 283.772 vs. MNPR (59.136). DOSEF has higher annual earnings (EBITDA): -296.52K vs. MNPR (-17.66M). MNPR has more cash in the bank: 54.6M vs. DOSEF (820K). DOSEF (0) and MNPR (0) have identical debt. DOSEF has higher revenues than MNPR: DOSEF (46.7K) vs MNPR (0).
DOSEFMNPRDOSEF / MNPR
Capitalization2.89M214M1%
EBITDA-296.52K-17.66M2%
Gain YTD283.77259.136480%
P/E RatioN/AN/A-
Revenue46.7K0-
Total Cash820K54.6M2%
Total Debt00-
TECHNICAL ANALYSIS
Technical Analysis
MNPR
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 23 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KNGLX11.630.06
+0.52%
Vest S&P500 Div Aristocrats Trgt Inc Inv
LCCAX36.44N/A
N/A
Columbia Contrarian Core A
IRVAX24.44N/A
N/A
Voya Russell Large Cap Value Idx Port A
TIOPX16.17N/A
N/A
Nuveen International Opps Prem
NEAIX53.24N/A
N/A
Needham Aggressive Growth Institutional

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and MNPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
MNPR - DOSEF
24%
Poorly correlated
+9.68%
AKRO - DOSEF
23%
Poorly correlated
+2.25%
SGMT - DOSEF
21%
Poorly correlated
-3.44%
ADAG - DOSEF
21%
Poorly correlated
-2.06%
CLRPF - DOSEF
12%
Poorly correlated
+5.07%
More

MNPR and

Correlation & Price change

A.I.dvisor tells us that MNPR and QNCX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and QNCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
+9.68%
QNCX - MNPR
31%
Poorly correlated
-6.25%
CVKD - MNPR
29%
Poorly correlated
-0.68%
AKBLF - MNPR
29%
Poorly correlated
N/A
BDRX - MNPR
26%
Poorly correlated
+1.93%
ZLAB - MNPR
25%
Poorly correlated
-2.08%
More